The goal of the NBCI Interactive Clinical Trials Portal is to offer a centralized location with critical information about how to improve the health outcomes of African-American and Latino communities. Access to such information will ensure their awareness of critical features, benefits, and challenges of what clinical trials entail.
The website particularly provides scientific facts and data-driven information that may positively influence the viewpoints of African-Americans and Latinos regarding their participation in clinical trials. The website attempts to demystify any misconceptions about clinical trials of African-Americans and/or Latinos. The website further seeks to support the understanding of African-American and Latinos about what is needed to answer questions, seek information, and approach toward gaining important insight about overall health outcomes.
In effect, the NBCI Interactive Clinical Trials Portal is poised to enhance the level of participation of African-Americans and Latinos in clinical trials and their subsequent acceptance of clinical trials as a viable option.
https://blackchurchclinicaltrials.com/faith-health.php
The National Black Church Initiative (NBCI), a coalition of 150,000 African-American and Latino churches with a population of 27.7 million, focuses on eradicating racial disparities in healthcare, clinical trials, technology, education, housing, and the environment. NBCI advocates for drug therapies to improve the overall health and well-being of African-Americans and Latinos.
There are eleven (11) pillars of NBCI Clinical Research Approaches to be used:
US regulatory agency is making a ‘big change’ to increase the number of participants from traditionally under-represented groups in drug testing. This will include African-Americans, Latinos, and other minoritized communities to be involved in clinical trials. The US Food and Drug Administration (FDA) will soon require researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants.
Search
An article by Ted Love, RealClear Health
Read More
An article by Alison Spencer and Cary Funk
Read More
PharmaTimes Magazine. April, 2023 edition
Read More
Settlement reached
Read More
FDA approves new drug
Read More
The Washington Post reveals that the loss of life came at a staggering cost, medically and economically
Read More
Time and again, it has been stressed that representation matters. Studies have shown it matters in education. It matters in the judicial system. And a new study shows it matters in the medical field.
Read More